(Q34339039)

1 August 2017

title

Adolescent and adult pertussis vaccination: computer simulations of five new strategies (English)

1 reference

1 August 2017

1 reference

1 reference

Annelies Van Rie

1

0 references

author name string

Herbert W Hethcote

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

1 August 2017

1 reference

1 August 2017

volume

22

1 reference

1 August 2017

issue

23-24

1 reference

1 August 2017

page(s)

3154-3165

1 reference

The science and fiction of the "resurgence" of pertussis.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Symptoms and complications of pertussis in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Frequency of unrecognized Bordetella pertussis infections in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Hospital admissions for pertussis in Spain, 1995-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Early infantile pertussis; increasingly prevalent and potentially fatal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Cellular and acellular pertussis vaccines in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Use of pertussis vaccine in an epidemic involving hospital staff

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Two primary doses of diphtheria-tetanus-acellular pertussis vaccine induce immunological responses to Bordetella pertussis as strong as those induced by three primary doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

A ten year follow-up after immunization with a two component acellular pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

An age-structured model for pertussis transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Pertussis in German adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Bordetella pertussis surveillance in England and Wales: 1995-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Epidemiology of pertussis in Denmark: the impact of herd immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Outcomes of Bordetella pertussis infection in different age groups of an immunized population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Intrafamilial spread of pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Pertussis infection in fully vaccinated children in day-care centers, Israel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Pertussis in adults: frequency of transmission after household exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

An epidemic of pertussis among elderly people in a religious institution in The Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

A pertussis outbreak in a Wisconsin nursing home.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Prevalence of pertussis IgG antibodies in children in Palermo, Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

How common is whooping cough in a nonvaccinating country?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Cumulative incidence of pertussis in an unvaccinated preschool cohort based on notifications, interview and serology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Modelling the impact of immunization on the epidemiology of varicella zoster virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Household contact study of Bordetella pertussis infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

The changing age and seasonal profile of pertussis in Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Deaths from pertussis are underestimated in England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

Pertussis of adults and infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

A pertussis epidemic in NSW: how epidemiology reflects vaccination policy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

inferred from DOI database lookup

7 January 2021

based on heuristic

Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

inferred from DOI database lookup

7 January 2021

based on heuristic

Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.067

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.01.067

1 reference

1 August 2017

1 reference